Colchicine

Generic Name
Colchicine
Brand Names
Colcrys, Gloperba, Lodoco, Mitigare
Drug Type
Small Molecule
Chemical Formula
C22H25NO6
CAS Number
64-86-8
Unique Ingredient Identifier
SML2Y3J35T
Background

Colchicine is an alkaloid drug derived from a plant belonging to the Lily family, known as Colchicum autumnale, or "autumn crocus." Its use was first approved by the FDA in 1961. Colchicine is used in the treatment of gout flares and Familial Mediterranean fever, and prevention of major cardiovascular events. It has also been investigated in other inflammato...

Indication

Colchicine is indicated for the prophylaxis and treatment of gout flares. It is also indicated in Familial Mediterranean fever (FMF) in children and adults of four years of age and older. It is also indicated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established ather...

Associated Conditions
Behcet's Syndrome, Cardiovascular Mortality, Coronary Revascularization, Familial Mediterranean Fever (FMF ), Gout Flares, Myocardial Infarction, Pericarditis, Postpericardiotomy Syndrome, Stroke
Associated Therapies
-

An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.

First Posted Date
2010-04-29
Last Posted Date
2019-08-07
Lead Sponsor
University of South Florida
Target Recruit Count
74
Registration Number
NCT01112982
Locations
🇺🇸

University of South Florida Medical Clinics, Tampa, Florida, United States

Healthy and Renal Impairment Study of Colcrys (Colchicine, USP)

Phase 4
Completed
Conditions
Interventions
First Posted Date
2010-03-10
Last Posted Date
2012-10-12
Lead Sponsor
Takeda
Target Recruit Count
40
Registration Number
NCT01084278
Locations
🇺🇸

West Coast Clinical Trials, Cypress, California, United States

A Pharmacokinetic Study of Colchicine With an Oral Contraceptive

First Posted Date
2009-12-30
Last Posted Date
2010-01-05
Lead Sponsor
Mutual Pharmaceutical Company, Inc.
Target Recruit Count
30
Registration Number
NCT01040845
Locations
🇺🇸

PRACS Institute, Ltd. - Cetero Research, Fargo, North Dakota, United States

Bioequivalence Study of Colchicine Tablets

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-11-26
Last Posted Date
2009-12-09
Lead Sponsor
Mutual Pharmaceutical Company, Inc.
Target Recruit Count
28
Registration Number
NCT01021020
Locations
🇺🇸

PRACS Institute, Ltd. - Cetero Research, Fargo, North Dakota, United States

Pharmacokinetic and Exploratory Electrocardiogram (ECG) Study

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-11-23
Last Posted Date
2009-12-01
Lead Sponsor
Mutual Pharmaceutical Company, Inc.
Target Recruit Count
18
Registration Number
NCT01018420
Locations
🇺🇸

PRACS Institute, Ltd. - Cetero Research, Fargo, North Dakota, United States

Colchicine for Diabetic Nephropathy

Phase 2
Conditions
Interventions
First Posted Date
2009-10-30
Last Posted Date
2013-01-04
Lead Sponsor
Prof.Avi Livneh
Target Recruit Count
12
Registration Number
NCT01005121
Locations
🇮🇱

Sheba medical center, Tel hashomer, Ramat gan, Israel

Drug-Drug Interaction Study Between Colchicine and Ketoconazole

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-09-24
Last Posted Date
2009-10-15
Lead Sponsor
Mutual Pharmaceutical Company, Inc.
Target Recruit Count
24
Registration Number
NCT00983216
Locations
🇺🇸

PRACS Institute, Ltd. - Cetero Research, Fargo, North Dakota, United States

Drug-Drug Interaction Study Between Colchicine and Cyclosporine

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-09-24
Last Posted Date
2009-10-15
Lead Sponsor
Mutual Pharmaceutical Company, Inc.
Target Recruit Count
24
Registration Number
NCT00983931
Locations
🇺🇸

PRACS Institute, Ltd. - Cetero Research, Fargo, North Dakota, United States

Drug-Drug Interaction Study Between Colchicine and Diltiazem ER

First Posted Date
2009-09-24
Last Posted Date
2009-10-15
Lead Sponsor
Mutual Pharmaceutical Company, Inc.
Target Recruit Count
24
Registration Number
NCT00983372
Locations
🇺🇸

PRACS Institute, Ltd. - Cetero Research, Fargo, North Dakota, United States

Drug-Drug Interaction Study of Colchicine and Theophylline

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-09-24
Last Posted Date
2010-03-02
Lead Sponsor
Mutual Pharmaceutical Company, Inc.
Target Recruit Count
30
Registration Number
NCT00983905
Locations
🇺🇸

PRACS Institute, Ltd. - Cetero Research, Fargo, North Dakota, United States

© Copyright 2024. All Rights Reserved by MedPath